BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 23797955)

  • 1. Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis.
    Clevenger L; Schrepf A; Degeest K; Bender D; Goodheart M; Ahmed A; Dahmoush L; Penedo F; Lucci J; Thaker PH; Mendez L; Sood AK; Slavich GM; Lutgendorf SK
    Cancer; 2013 Sep; 119(17):3234-41. PubMed ID: 23797955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.
    Joly F; Ahmed-Lecheheb D; Kalbacher E; Heutte N; Clarisse B; Grellard JM; Gernier F; Berton-Rigaud D; Tredan O; Fabbro M; Savoye AM; Kurtz JE; Alexandre J; Follana P; Delecroix V; Dohollou N; Roemer-Becuwe C; De Rauglaudre G; Lortholary A; Prulhiere K; Lesoin A; Zannetti A; N'Guyen S; Trager-Maury S; Chauvenet L; Abadie Lacourtoisie S; Gompel A; Lhommé C; Floquet A; Pautier P
    Ann Oncol; 2019 May; 30(5):845-852. PubMed ID: 30851097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported distress in patients with ovarian cancer: is it related to disease status?
    Ploos van Amstel FK; van Ham MA; Peters EJ; Prins JB; Ottevanger PB
    Int J Gynecol Cancer; 2015 Feb; 25(2):229-35. PubMed ID: 25594140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic difficulties are associated with poorer psychosocial functioning in the first year post-diagnosis in epithelial ovarian cancer patients.
    Garvin L; Slavich GM; Schrepf A; Davis LZ; Thaker PH; Goodheart MJ; Cole SW; Sood AK; Lutgendorf SK
    Psychooncology; 2021 Jun; 30(6):954-961. PubMed ID: 33760306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical activity in women with ovarian cancer and its association with decreased distress and improved quality of life.
    Beesley VL; Price MA; Butow PN; Green AC; Olsen CM; ; ; Webb PM
    Psychooncology; 2011 Nov; 20(11):1161-9. PubMed ID: 20740686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing quality of life, anxiety, depression, sleep disturbance, and associated factors in vitiligo and alopecia areata patients.
    Ghalamkarpour F; Araghi F; Tabari M; Moslemi Haghighi S; Pourgholi E
    J Cosmet Dermatol; 2024 May; 23(5):1808-1815. PubMed ID: 38169098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina.
    Haybar H; Javid AZ; Haghighizadeh MH; Valizadeh E; Mohaghegh SM; Mohammadzadeh A
    Clin Nutr ESPEN; 2018 Aug; 26():47-52. PubMed ID: 29908682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients.
    Brown AJ; Sun CC; Urbauer DL; Bodurka DC; Thaker PH; Ramondetta LM
    Gynecol Oncol; 2015 Aug; 138(2):388-93. PubMed ID: 25988961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caring for women with ovarian cancer in the last year of life: a longitudinal study of caregiver quality of life, distress and unmet needs.
    Butow PN; Price MA; Bell ML; Webb PM; deFazio A; ; ; Friedlander M
    Gynecol Oncol; 2014 Mar; 132(3):690-7. PubMed ID: 24423880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of epithelial ovarian cancer diagnosis on women's life: a qualitative study.
    Mangone L; Mandato VD; Gandolfi R; Tromellini C; Abrate M
    Eur J Gynaecol Oncol; 2014; 35(1):32-8. PubMed ID: 24654458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of fatigue and fatigability correlates in Korean breast cancer survivors and differences in associations with anxiety, depression, sleep disturbance, and endocrine symptoms: a randomized controlled trial.
    Jang MK; Han J; Kim SH; Ko YH; Kim SY; Kim S
    BMC Cancer; 2021 Jul; 21(1):855. PubMed ID: 34311713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients.
    Lutgendorf SK; Slavich GM; Degeest K; Goodheart M; Bender D; Thaker PH; Penedo F; Zimmerman B; Lucci J; Mendez L; Collins K; Sood AK
    Gynecol Oncol; 2013 Dec; 131(3):667-73. PubMed ID: 24096110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer.
    Bodurka-Bevers D; Basen-Engquist K; Carmack CL; Fitzgerald MA; Wolf JK; de Moor C; Gershenson DM
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):302-8. PubMed ID: 10985884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early postoperative psychological distress as a mediator of subsequent persistent postsurgical pain outcomes among younger breast cancer patients.
    Wilson JM; Colebaugh CA; Flowers KM; Edwards RR; Partridge AH; Dominici LS; Schreiber KL
    Breast Cancer Res Treat; 2022 Nov; 196(2):363-370. PubMed ID: 36103023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep quality and psychological disorders in breast cancer female patients receiving radiotherapy at a tertiary oncology center in West Saudi Arabia.
    Elamin N; Althebity N; Alkhamisi TA; Al-Foheidi M
    Support Care Cancer; 2024 Feb; 32(3):163. PubMed ID: 38367029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sleep disturbance on quality of life in women with ovarian cancer.
    Sandadi S; Frasure HE; Broderick MJ; Waggoner SE; Miller JA; von Gruenigen VE
    Gynecol Oncol; 2011 Nov; 123(2):351-5. PubMed ID: 21855973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group-based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancers.
    Manne SL; Myers-Virtue S; Kissane D; Ozga ML; Kashy DA; Rubin SC; Rosenblum NG; Heckman CJ
    Psychooncology; 2017 Nov; 26(11):1799-1809. PubMed ID: 27421919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study.
    Sjoquist KM; Friedlander ML; O'Connell RL; Voysey M; King MT; Stockler MR; Oza AM; Gillies K; Martyn JK; Butow PN
    Oncologist; 2013; 18(11):1221-8. PubMed ID: 24107972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mental Health, Sleep and Physical Function in Treatment Seeking Women with Urinary Incontinence.
    Siddiqui NY; Wiseman JB; Cella D; Bradley CS; Lai HH; Helmuth ME; Smith AR; Griffith JW; Amundsen CL; Kenton KS; Clemens JQ; Kreder KJ; Merion RM; Kirkali Z; Kusek JW; Cameron AP;
    J Urol; 2018 Oct; 200(4):848-855. PubMed ID: 29730202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies.
    Huang T; Poole EM; Okereke OI; Kubzansky LD; Eliassen AH; Sood AK; Wang M; Tworoger SS
    Gynecol Oncol; 2015 Dec; 139(3):481-6. PubMed ID: 26449316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.